Credit Suisse’s Clearside Biomedical CLSD Stock Holding History

Credit Suisse’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$38.3K	Buy	+1,667	New	+$35.9K	﹤0.01%	2945
2019 Q2	–	Sell	-731	Closed	-$15K	–	4101
2019 Q1	$15K	Buy	+731	New	+$14.5K	﹤0.01%	3949
2017 Q4	–	Sell	-1,015	Closed	-$133K	–	4006
2017 Q3	$133K	Buy	+1,015	New	+$124K	﹤0.01%	4033
2017 Q1	–	Sell	-847	Closed	-$114K	–	3833
2016 Q4	$114K	Sell	847 -369	-30%	-$92.6K	﹤0.01%	3935
2016 Q3	$316K	Buy	+1,216	New	+$149K	﹤0.01%	3638

Other funds holding CLSD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Credit Suisse's CLSD Position: Q1 2024 in Review

Credit Suisse opened a new position in Clearside Biomedical (CLSD) in Q1 2024: 1,667 shares worth $38.3K. The stake represents ﹤0.01% of the portfolio and ranks #2945 among its holdings. This is a return to the name: Credit Suisse previously reported a position in CLSD as recently as Q1 2019.

Credit Suisse first reported a position in CLSD in Q3 2016 and has held it in 5 quarters since. The position peaked at $316K in Q3 2016. 51 funds tracked by Wall St. Rank hold CLSD as of Q1 2024.

Credit Suisse held 1,667 shares of Clearside Biomedical worth $38.3K as of Q1 2024.
Clearside Biomedical was a new Credit Suisse position in Q1 2024.
Clearside Biomedical made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2945 holding.
Credit Suisse first reported a position in Clearside Biomedical in Q3 2016 and has held it in 5 quarters since.
Credit Suisse's Clearside Biomedical position peaked at $316K in Q3 2016.
51 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.